BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 20673233)

  • 1. Interorgan ammonia metabolism in liver failure: the basis of current and future therapies.
    Wright G; Noiret L; Olde Damink SW; Jalan R
    Liver Int; 2011 Feb; 31(2):163-75. PubMed ID: 20673233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. To pee or not to pee: ammonia hypothesis of hepatic encephalopathy revisited.
    Mpabanzi L; Olde Damink SW; van de Poll MC; Soeters PB; Jalan R; Dejong CH
    Eur J Gastroenterol Hepatol; 2011 Jun; 23(6):449-54. PubMed ID: 21537121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interorgan ammonia, glutamate, and glutamine trafficking in pigs with acute liver failure.
    Ytrebø LM; Sen S; Rose C; Ten Have GA; Davies NA; Hodges S; Nedredal GI; Romero-Gomez M; Williams R; Revhaug A; Jalan R; Deutz NE
    Am J Physiol Gastrointest Liver Physiol; 2006 Sep; 291(3):G373-81. PubMed ID: 16782695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Disturbances in ammonia metabolism in hepatic failure].
    Ytrebø LM
    Tidsskr Nor Laegeforen; 2007 May; 127(11):1514-7. PubMed ID: 17551556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current state of knowledge of hepatic encephalopathy (part I): newer treatment strategies for hyperammonemia in liver failure.
    Kristiansen RG
    Metab Brain Dis; 2016 Dec; 31(6):1357-1358. PubMed ID: 27651377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of a vicious cycle in glutamine synthesis and breakdown in pathogenesis of hepatic encephalopathy-therapeutic perspectives.
    Holecek M
    Metab Brain Dis; 2014 Mar; 29(1):9-17. PubMed ID: 23996300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ammonia-lowering strategies for the treatment of hepatic encephalopathy.
    Rose CF
    Clin Pharmacol Ther; 2012 Sep; 92(3):321-31. PubMed ID: 22871998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New concepts in the physiopathology of hepatic encephalopathy and therapeutic prospects].
    Romero Gómez M; Bautista JD; Grande L; Ramos Guerrero RM; Sánchez Muñoz D
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():40-8. PubMed ID: 15195533
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of hepatic encephalopathy in patients with cirrhosis.
    Wright G; Jalan R
    Best Pract Res Clin Gastroenterol; 2007; 21(1):95-110. PubMed ID: 17223499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ammonia content and glutamine synthetase and glutaminase activity in the brain in experimental hepatic coma].
    Hilgier W
    Neuropatol Pol; 1981; 19(3):351-8. PubMed ID: 6119654
    [No Abstract]   [Full Text] [Related]  

  • 11. Cerebral metabolic disturbances in the brain during acute liver failure: from hyperammonemia to energy failure and proteolysis.
    Ott P; Clemmesen O; Larsen FS
    Neurochem Int; 2005 Jul; 47(1-2):13-8. PubMed ID: 15921824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy.
    Blanco Vela CI; Poo Ramírez JL
    Ann Hepatol; 2011 Jun; 10 Suppl 2():S55-9. PubMed ID: 22228883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on the role of brain glutamine synthesis and its relation to cell-specific energy metabolism in the hyperammonemic brain: further studies using NMR spectroscopy.
    Zwingmann C; Butterworth R
    Neurochem Int; 2005 Jul; 47(1-2):19-30. PubMed ID: 15916833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splanchnic circulation and metabolism in patients with acute liver failure.
    Clemmesen O
    Dan Med Bull; 2002 Aug; 49(3):177-93. PubMed ID: 12238280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of extracellular cGMP and of hyperammonemia in the impairment of learning in rats with chronic hepatic failure. Therapeutic implications.
    Erceg S; Monfort P; Cauli O; Montoliu C; Llansola M; Piedrafita B; Felipo V
    Neurochem Int; 2006; 48(6-7):441-6. PubMed ID: 16497413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interorgan ammonia metabolism in liver failure.
    Olde Damink SW; Deutz NE; Dejong CH; Soeters PB; Jalan R
    Neurochem Int; 2002; 41(2-3):177-88. PubMed ID: 12020618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy.
    Jalan R; Wright G; Davies NA; Hodges SJ
    Med Hypotheses; 2007; 69(5):1064-9. PubMed ID: 17467190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear magnetic resonance studies of energy metabolism and glutamine shunt in hepatic encephalopathy and hyperammonemia.
    Zwingmann C
    J Neurosci Res; 2007 Nov; 85(15):3429-42. PubMed ID: 17722064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult onset urea cycle disorder in a patient with presumed hepatic encephalopathy.
    Atiq M; Holt AF; Safdar K; Weber F; Ravinuthala R; Jonas ME; Neff GW
    J Clin Gastroenterol; 2008 Feb; 42(2):213-4. PubMed ID: 18209596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal ammonia and glutamine metabolism during liver insufficiency-induced hyperammonemia in the rat.
    Dejong CH; Deutz NE; Soeters PB
    J Clin Invest; 1993 Dec; 92(6):2834-40. PubMed ID: 7902848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.